Lucid Diligence Brief - Tech

Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration

Lucid Diligence Brief: Manifold Bio and Roche brain-shuttle collaboration…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Thermo Fisher to acquire Clario

Lucid Diligence Brief: Thermo Fisher to acquire Clario Professional audiences…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027

Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027 Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka

Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Human Health A$8.5m raise in women’s health

Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera

Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration

Lucid Diligence Brief: ModeX Therapeutics and Regeneron collaboration…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership

Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD

Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC

Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC Professional…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Guardant Health and Zephyr AI partnership

Lucid Diligence Brief: Guardant Health and Zephyr AI partnership Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…


Privacy Preference Center